Moreover, the use of anti-human IL-6R antibody significantly inhibited NPC cell growth and invasion, suggesting blockade of IL6/IL6R is a potential therapeutic target to treat NPC metastasis. Here, IL6 is linked to nasopharyngeal carcinoma.